These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 16938526)

  • 1. Synemin expression is widespread in liver fibrosis and is induced in proliferating and malignant biliary epithelial cells.
    Schmitt-Graeff A; Jing R; Nitschke R; Desmoulière A; Skalli O
    Hum Pathol; 2006 Sep; 37(9):1200-10. PubMed ID: 16938526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: 'bile ductular carcinoma'.
    Kozaka K; Sasaki M; Fujii T; Harada K; Zen Y; Sato Y; Sawada S; Minato H; Matsui O; Nakanuma Y
    Histopathology; 2007 Sep; 51(3):390-400. PubMed ID: 17553067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative immunohistochemical expression of p63 in human cholangiocarcinoma and hepatocellular carcinoma.
    Ramalho FS; Ramalho LN; Della Porta L; Zucoloto S
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1276-80. PubMed ID: 16872309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrahepatic cholangiocarcinoma arising in cirrhotic liver frequently expressed p63-positive basal/stem-cell phenotype.
    Nomoto K; Tsuneyama K; Cheng C; Takahashi H; Hori R; Murai Y; Takano Y
    Pathol Res Pract; 2006; 202(2):71-6. PubMed ID: 16377099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synemin down-regulation in human hepatocellular carcinoma does not destabilize cytoskeletons in vivo.
    Liu YH; Cheng CC; Lai YS; Chao WT; Pei RJ; Hsu YH; Ho CC
    Biochem Biophys Res Commun; 2011 Jan; 404(1):488-93. PubMed ID: 21144834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High mobility group A1 is expressed in metastatic adenocarcinoma to the liver and intrahepatic cholangiocarcinoma, but not in hepatocellular carcinoma: its potential use in the diagnosis of liver neoplasms.
    Abe N; Watanabe T; Izumisato Y; Suzuki Y; Masaki T; Mori T; Sugiyama M; Fusco A; Atomi Y
    J Gastroenterol; 2003; 38(12):1144-9. PubMed ID: 14714251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the expression of agrin, a basement membrane heparan sulfate proteoglycan, in cholangiocarcinoma and hepatocellular carcinoma.
    Batmunkh E; Tátrai P; Szabó E; Lódi C; Holczbauer A; Páska C; Kupcsulik P; Kiss A; Schaff Z; Kovalszky I
    Hum Pathol; 2007 Oct; 38(10):1508-15. PubMed ID: 17640714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium iodide symporter is expressed at the preneoplastic stages of liver carcinogenesis and in human cholangiocarcinoma.
    Liu B; Hervé J; Bioulac-Sage P; Valogne Y; Roux J; Yilmaz F; Boisgard R; Guettier C; Calès P; Tavitian B; Samuel D; Clerc J; Bréchot C; Faivre J
    Gastroenterology; 2007 Apr; 132(4):1495-503. PubMed ID: 17408651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined hepatocellular carcinoma and cholangiocarcinoma with components of mucinous carcinoma arising in a cirrhotic liver.
    Morita D; Kagata Y; Ogata S; Tsuda H; Hatsuse K; Mochizuki H; Matsubara O
    Pathol Int; 2006 Apr; 56(4):222-6. PubMed ID: 16634969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular retinol-binding protein-1 expression in normal and fibrotic/cirrhotic human liver: different patterns of expression in hepatic stellate cells and (myo)fibroblast subpopulations.
    Lepreux S; Bioulac-Sage P; Gabbiani G; Sapin V; Housset C; Rosenbaum J; Balabaud C; Desmoulière A
    J Hepatol; 2004 May; 40(5):774-80. PubMed ID: 15094224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique epithelial cell production of hepatocyte growth factor/scatter factor by putative precancerous intestinal metaplasias and associated "intestinal-type" biliary cancer chemically induced in rat liver.
    Lai GH; Radaeva S; Nakamura T; Sirica AE
    Hepatology; 2000 Jun; 31(6):1257-65. PubMed ID: 10827151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
    Tátrai P
    Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic stellate cells express synemin, a protein bridging intermediate filaments to focal adhesions.
    Uyama N; Zhao L; Van Rossen E; Hirako Y; Reynaert H; Adams DH; Xue Z; Li Z; Robson R; Pekny M; Geerts A
    Gut; 2006 Sep; 55(9):1276-89. PubMed ID: 16484507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Glut-1 expression in cholangiocarcinoma, benign biliary lesions and hepatocellular carcinoma.
    Zimmerman RL; Fogt F; Burke M; Murakata LA
    Oncol Rep; 2002; 9(4):689-92. PubMed ID: 12066193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered synemin could affect the organization of intermediate filament in human hepatocellular carcinoma.
    Ho CC; Ho HC; Liu YH; Pei RJ; Cheng CC; Lee KY; Yeh KT; Lai YS
    J Med; 2004; 35(1-6):171-80. PubMed ID: 18084875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocarcinoma-intestine-pancreas/pancreatic associated protein (HIP/PAP) is expressed and secreted by proliferating ductules as well as by hepatocarcinoma and cholangiocarcinoma cells.
    Christa L; Simon MT; Brezault-Bonnet C; Bonte E; Carnot F; Zylberberg H; Franco D; Capron F; Roskams T; Bréchot C
    Am J Pathol; 1999 Nov; 155(5):1525-33. PubMed ID: 10550309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clusterin expression in cholestasis, hepatocellular carcinoma and liver fibrosis.
    Aigelsreiter A; Janig E; Sostaric J; Pichler M; Unterthor D; Halasz J; Lackner C; Zatloukal K; Denk H
    Histopathology; 2009 Apr; 54(5):561-70. PubMed ID: 19413638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatic neoductules].
    Fischer HP; Meybehm M; Zhou H; Schoch J
    Verh Dtsch Ges Pathol; 1995; 79():36-46. PubMed ID: 8600693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of endogenous galectin-1 and galectin-3 in intrahepatic cholangiocarcinoma.
    Shimonishi T; Miyazaki K; Kono N; Sabit H; Tuneyama K; Harada K; Hirabayashi J; Kasai K; Nakanuma Y
    Hum Pathol; 2001 Mar; 32(3):302-10. PubMed ID: 11274640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrahepatic cholangiocarcinoma arising in chronic advanced liver disease and the cholangiocarcinomatous component of hepatocellular cholangiocarcinoma share common phenotypes and cholangiocarcinogenesis.
    Xu J; Sasaki M; Harada K; Sato Y; Ikeda H; Kim JH; Yu E; Nakanuma Y
    Histopathology; 2011 Dec; 59(6):1090-9. PubMed ID: 22175889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.